S-1: BIO-key International Files for Resale of Up to 2,061,112 Shares of Common Stock

BIO-key International is registering the resale of up to 2,061,112 shares of its common stock by a selling stockholder, with the company not receiving any proceeds from the sale.

Summary

• BIO-key International has filed a registration statement for the resale of up to 2,061,112 shares of its common stock.
• The shares are to be sold by a selling stockholder, Armistice Capital Master Fund Ltd.
• The shares consist of common stock issuable upon the exercise of Series A and Series B warrants.
• BIO-key will not receive any proceeds from the sale of these shares by the selling stockholder.
• If all warrants are exercised, BIO-key would receive gross proceeds of $3,813,057.20.
• The company intends to use these proceeds for working capital and general corporate purposes, including repaying a portion of its secured note.
• The common stock is listed on the Nasdaq Capital Market under the symbol BKYI.
• As of October 10, 2024, the closing price of BIO-key's common stock was $0.65 per share.
• As of October 11, 2024, BIO-key had 3,109,288 shares of common stock outstanding.

Sentiment

Score: 5

Explanation: Neutral sentiment. The document primarily outlines the terms of a stock resale and potential warrant exercises. While the potential capital injection is positive, the lack of proceeds from the resale and potential stock dilution temper the outlook.

Positives

• The potential exercise of warrants could bring in $3,813,057.20 in gross proceeds to BIO-key.
• The company intends to use these proceeds for working capital and general corporate purposes, including repayment of a portion of its secured note.

Negatives

• BIO-key will not receive any proceeds from the sale of shares by the selling stockholder.
• Sales of a substantial number of shares of our common stock in the public market, including the shares offered under this prospectus, could lower our stock price and impair our ability to raise funds in new stock offerings.
• An active trading market for our shares may not be sustained.

Risks

• Sales of a substantial number of shares of our common stock in the public market, including the shares offered under this prospectus, could lower our stock price and impair our ability to raise funds in new stock offerings.
• An active trading market for our shares may not be sustained.
• Investing in our securities involves a high degree of risk and purchasers of our securities may lose their entire investment.

Future Outlook

BIO-key expects to grow its business within highly-regulated industries and expects to continue to extend this footprint in 2024 and beyond. The company believes that continued heightened security and privacy requirements will generate increased demand for security solutions, including biometrics.

Industry Context

BIO-key operates in the identity and access management (IAM) market, which is experiencing growth due to increasing cybersecurity threats and the need for secure remote access solutions. The company differentiates itself with phone-less and token-less biometric authentication methods.

Stakeholder Impact

• Existing shareholders may experience dilution if the warrants are exercised and the shares are sold into the market.
• The company's ability to fund operations and repay debt could be improved if the warrants are exercised.
• The selling stockholder will realize proceeds from the sale of the shares.

Next Steps

• The selling stockholder may sell the shares covered by this prospectus through public or private transactions at prevailing market prices or at privately negotiated prices.
• The company will use commercially reasonable efforts to have such resale registration statement declared effective by the SEC within 60 calendar days following the date of the Warrant Exercise Agreement (or within 90 calendar days following the date of the Warrant Exercise Agreement in case of a full review of such registration statement by the SEC).

Key Dates

Keywords

common stock, resale, warrants, BIO-key, offering, shares, securities